Supernus Pharmaceuticals Inc (SUPN)
Net Receivables
$211.66M
Quarterly · Period ending: · USD
SUPN Net Receivables
Latest reported$211.66Mperiod ending
Latest reported$211.66Mperiod ending
SUPN Quarterly Net Receivables ($3.74M → $211.66M)
Quarterly net receivables
High-resolution chart · PNG
SUPN net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 211,656,000 | |
| 182,183,000 | |
| 187,802,000 | |
| 171,254,000 | |
| 140,831,000 | |
| 145,640,000 | |
| 142,077,000 | |
| 145,408,000 | |
| 152,494,000 | |
| 147,734,000 | |
| 144,155,000 | |
| 141,764,000 | |
| 136,556,000 | |
| 143,568,000 | |
| 165,497,000 | |
| 164,086,000 | |
| 158,063,000 | |
| 145,149,000 | |
| 148,932,000 | |
| 133,676,000 | |
| 137,275,000 | |
| 127,065,000 | |
| 140,877,000 | |
| 133,107,000 | |
| 126,559,000 | |
| 119,195,000 | |
| 87,332,000 | |
| 86,699,000 | |
| 84,564,000 | |
| 79,950,000 | |
| 102,922,000 | |
| 77,753,000 | |
| 74,842,000 | |
| 67,864,000 | |
| 65,586,000 | |
| 56,166,000 | |
| 51,157,000 | |
| 38,885,000 | |
| 41,527,000 | |
| 36,220,000 | |
| 34,281,000 | |
| 30,651,000 | |
| 25,908,000 | |
| 23,603,000 | |
| 17,900,000 | |
| 19,271,000 | |
| 17,270,000 | |
| 15,796,000 | |
| 11,350,000 | |
| 10,361,000 | |
| 5,054,000 | |
| 8,190,000 | |
| 1,328,000 | |
| 2,322,000 | |
| 675,000 | |
| 500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 3,978,000 | |
| 158,000 | |
| 3,118,869 | |
| 3,742,000 |